1. Home
  2. IRWD vs NDMO Comparison

IRWD vs NDMO Comparison

Compare IRWD & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • NDMO
  • Stock Information
  • Founded
  • IRWD 1998
  • NDMO 2019
  • Country
  • IRWD United States
  • NDMO United States
  • Employees
  • IRWD N/A
  • NDMO N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • NDMO Trusts Except Educational Religious and Charitable
  • Sector
  • IRWD Health Care
  • NDMO Finance
  • Exchange
  • IRWD Nasdaq
  • NDMO Nasdaq
  • Market Cap
  • IRWD 734.5M
  • NDMO 596.2M
  • IPO Year
  • IRWD 2010
  • NDMO N/A
  • Fundamental
  • Price
  • IRWD $3.66
  • NDMO $10.37
  • Analyst Decision
  • IRWD Buy
  • NDMO
  • Analyst Count
  • IRWD 4
  • NDMO 0
  • Target Price
  • IRWD $12.00
  • NDMO N/A
  • AVG Volume (30 Days)
  • IRWD 2.4M
  • NDMO 218.6K
  • Earning Date
  • IRWD 02-13-2025
  • NDMO 01-01-0001
  • Dividend Yield
  • IRWD N/A
  • NDMO 6.75%
  • EPS Growth
  • IRWD N/A
  • NDMO N/A
  • EPS
  • IRWD N/A
  • NDMO N/A
  • Revenue
  • IRWD $378,418,000.00
  • NDMO N/A
  • Revenue This Year
  • IRWD N/A
  • NDMO N/A
  • Revenue Next Year
  • IRWD N/A
  • NDMO N/A
  • P/E Ratio
  • IRWD N/A
  • NDMO N/A
  • Revenue Growth
  • IRWD N/A
  • NDMO N/A
  • 52 Week Low
  • IRWD $3.06
  • NDMO $8.99
  • 52 Week High
  • IRWD $15.70
  • NDMO $11.24
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 40.23
  • NDMO 57.84
  • Support Level
  • IRWD $3.56
  • NDMO $10.08
  • Resistance Level
  • IRWD $3.88
  • NDMO $10.25
  • Average True Range (ATR)
  • IRWD 0.31
  • NDMO 0.11
  • MACD
  • IRWD -0.10
  • NDMO 0.05
  • Stochastic Oscillator
  • IRWD 10.40
  • NDMO 100.00

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest

Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. The investment objective of the Fund is to seek total return through income exempt from regular federal income taxes and capital appreciation.

Share on Social Networks: